1. Home
  2. CAC vs PLRX Comparison

CAC vs PLRX Comparison

Compare CAC & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAC
  • PLRX
  • Stock Information
  • Founded
  • CAC 1875
  • PLRX 2015
  • Country
  • CAC United States
  • PLRX United States
  • Employees
  • CAC N/A
  • PLRX N/A
  • Industry
  • CAC Major Banks
  • PLRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CAC Finance
  • PLRX Health Care
  • Exchange
  • CAC Nasdaq
  • PLRX Nasdaq
  • Market Cap
  • CAC N/A
  • PLRX 77.3M
  • IPO Year
  • CAC 1997
  • PLRX 2020
  • Fundamental
  • Price
  • CAC $43.17
  • PLRX $1.44
  • Analyst Decision
  • CAC Hold
  • PLRX Hold
  • Analyst Count
  • CAC 3
  • PLRX 10
  • Target Price
  • CAC $47.33
  • PLRX $9.79
  • AVG Volume (30 Days)
  • CAC 66.0K
  • PLRX 1.6M
  • Earning Date
  • CAC 07-29-2025
  • PLRX 08-06-2025
  • Dividend Yield
  • CAC 3.95%
  • PLRX N/A
  • EPS Growth
  • CAC 2.54
  • PLRX N/A
  • EPS
  • CAC 3.09
  • PLRX N/A
  • Revenue
  • CAC $184,324,000.00
  • PLRX N/A
  • Revenue This Year
  • CAC $40.83
  • PLRX N/A
  • Revenue Next Year
  • CAC $5.29
  • PLRX N/A
  • P/E Ratio
  • CAC $13.80
  • PLRX N/A
  • Revenue Growth
  • CAC 13.26
  • PLRX N/A
  • 52 Week Low
  • CAC $33.83
  • PLRX $1.10
  • 52 Week High
  • CAC $50.07
  • PLRX $16.10
  • Technical
  • Relative Strength Index (RSI)
  • CAC 70.29
  • PLRX 55.31
  • Support Level
  • CAC $42.85
  • PLRX $1.13
  • Resistance Level
  • CAC $43.78
  • PLRX $1.27
  • Average True Range (ATR)
  • CAC 0.98
  • PLRX 0.11
  • MACD
  • CAC 0.37
  • PLRX 0.03
  • Stochastic Oscillator
  • CAC 95.06
  • PLRX 93.33

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

Share on Social Networks: